Immunocore Holdings plc Accounts Payable

Immunocore Holdings plc (IMCR) currently reports a accounts payable of $26M as of June 2026. That compares with $24M in the prior-year period — up 10.3% year over year. Use the charts on this page to explore Immunocore Holdings plc's accounts payable history and peer comparisons.

Immunocore Holdings plc's accounts payable increased from $24M to $26M — a 10.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immunocore Holdings plc reported $26M in accounts payable as of June 2026. That compares with $24M in the prior-year period — up 10.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $26M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunocore Holdings plc, and consider following IMCR for alerts when major investors trade the stock.

Immunocore Holdings plc is classified in the Healthcare sector. On accounts payable, it currently shows $26M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMCR with unrelated industries.